Mckesson (MCK) stock
Last close $1,062.16 on 2026-11-19 (-2.05%) · Sector: Healthcare
McKesson is a large healthcare company that distributes prescription drugs, medical supplies, and other products to pharmacies, hospitals, clinics, and other providers. It also sells healthcare technology and software that help providers run their businesses. It earns money mostly by moving very large volumes of products at small profit per item, so its profit margins are thin.
McKesson is growing its revenue, with trailing 12-month revenue growth of 8.2%, and its latest quarter brought in about $111.0 billion. Its shares have returned 25.0% over the past year, beating the S&P 500's 9.7% return. The stock sits 5.3% below its 52-week high, and insiders have sold about $2.2 million of stock over the last 90 days without any buys. Its results have also moved the stock sharply at times, rising 16.5% the day after its February 2026 earnings report.
Key numbers
- Market cap: $124.0B
- Revenue (last 12 months): $418.80B
- Revenue growth: +8.2%
- Gross margin: 3.7%
- Operating margin: 1.6%
- P/S: 0.3
- Current ratio: 0.90
Quality score
Overall 42/100 · growth 37 · profitability 22 · financial health 67 · value None
Performance and risk
1-year return +25.0% vs S&P 500 +9.7% · volatility 31.8% (S&P 500 13.8%) · largest drop -27.2% · beta -0.13
Stock move the day after earnings
- 2026-02-04: +16.5%
- 2026-05-07: -2.5%
- 2026-08-05: -0.7%
- 2026-11-04: +0.2%
Insider trades (12 months)
Bought $0.0M · sold $30.1M
MCK stock research · MCK options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.